Table 2.
The different primers used in this work
CD18 mRNA amplification | ||
Coding | Non-coding | Size (bp) |
CD18-1: TATAAGCTTCAGGGCAGACTGGTAGCAAA | CD18–4: CTTAGCAAGCTTGTGCGCCA | 1–1007 |
CD18-5: AACGAATTCGACTACCCATCGGT | CD18–8: CTAGAATTCTCCTGACGGCCTTGTCTTCA | 970–2410 |
HVS genome amplification | ||
Coding | Non-coding | Size (bp) |
HVS.1: GAGTTTCCAAAATGTACTAAGCTAAC | HVS.2-ACTAATAAAAAGTTCCACACAACTAAC | 89 |
CD18 genomic DNA amplification | ||
Coding | Non-coding | Localization (size bp) |
CD18-1.1: GACATCATGGACCCCACAAGC | CD18–1·2: CTTCAGCACGTGCCTGAAGGC | Exon 4–exon 6 (5400) |
I4F-1: CTGAAACTCCAGCCTGCCTGG | I5R-2: TACAAGTGTTGGGGAGCCAGG | Intron 4–intron 5 (572) |
Direct sequencing | ||
Primer | Localization | |
CD18-2: | AACAAGCTTCTTGACATTCC | Exon 5 |
CD18-3: | TCCAAGCTTGATGACCTCAG | Exon 5 |
I5R-2: | TACAAGTGTTGGGGAGCCAGG | Intron 5 |
I5R-1: | AGATGGAAGGGGAAGTGGAGG | Intron 5 |
Competitive PCR analysis | ||
Coding | Non-coding | Localization (size bp) |
E4-FM: TAMRA-CTTCACAGGGCCGGGGGATCC | E4-R: CTGGTCGCAGGTAAAGCGTCT | Exon 4 (180) |
E5-RM: TAMRA-GTCCTGCAGTGCCTGGGCC | I4F-3: GGGGAGAGGGGAGGTCAGGAG | Exon 5–intron 4 (*) |
E6-FM: TAMRA-CTTCGGGTCCTTCGTGGACAAG | E6-R: GGGCAGGCGGCGACCTGCATCA | Exon 6 (240) |
Amplified size in CT-HVS was 331 bp and in LAD-HVS was 162 bp.